Nomura Holdings’s GSK GSK Stock Holding History

Nomura Holdings’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-640,000	Closed	-$35M	–	1804
2022 Q2	$35M	Buy	+640,000	New	+$35.3M	0.12%	104
2021 Q2	–	Sell	-2,240	Closed	-$102K	–	2143
2021 Q1	$102K	Buy	+2,240	New	+$102K	﹤0.01%	1702
2015 Q1	–	Sell	-42,880	Closed	-$2.29M	–	1973
2014 Q4	$2.29M	Sell	42,880 -80,320	-65%	-$4.49M	0.01%	986
2014 Q3	$7.09M	Buy	123,200 +80,320	+187%	+$4.92M	0.02%	564
2014 Q2	$2.87M	Hold	42,880	–	–	﹤0.01%	955
2014 Q1	$2.87M	Buy	+42,880	New	+$2.9M	﹤0.01%	999

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's GSK Position: Q3 2024 in Review

Nomura Holdings sold out of GSK (GSK) in Q3 2024, closing a stake of 25,124 shares — an estimated $967K sold.

Nomura Holdings first reported a position in GSK in Q2 2013 and held it in 26 quarters. The position peaked at $193M in Q4 2021. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

Nomura Holdings reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
Nomura Holdings sold 25,124 GSK shares in Q3 2024, an estimated $967K.
Nomura Holdings first reported a position in GSK in Q2 2013 and held it in 26 quarters.
Nomura Holdings's GSK position peaked at $193M in Q4 2021.
899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.